Matthew Perrone

Associated Press

More from Matthew Perrone

In this Dec. 20, 2018, file photo Juul products are displayed at a smoke shop in New York.

Feds to Breakup Altria-Juul Deal

The complaint alleges that Altria agreed not to compete against Juul in return for the $13 billion stake in the company.

Zantac tablets at a pharmacy in Miami Beach, Fla.

FDA Demands Recall

It was determined that a contamination issue with the medications poses a greater risk than previously thought.

In this July 9, 2015, file photo, a man walks outside the headquarters of Gilead Sciences in Foster City, Calif. Gilead Sciences said Wednesday, March 25, 2020 it will give up the specialty status it received days earlier for its COVID-19 drug amid public outrage that the company was seeking to boost the profits of its treatment.

Drugmaker Backpedals on Drug Status

Classifying this widespread disease as 'rare' meant Gilead could block competition.

Gilead Sciences CEO Daniel O'Day speaks at a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House in Washington.

Virus Treatment Granted 'Orphan Drug' Status

Experts say the request seems inappropriate given the rapidly expanding threat.

In this March 11 photo, a technician prepares COVID-19 coronavirus patient samples for testing at a laboratory in New York's Long Island. Wide-scale testing is a critical part of tracking and containing infectious diseases. But the U.S. effort has been plagued by a series of missteps, including accuracy problems with the test kits the CDC sent to other labs and bureaucratic hurdles that slowed the entrance of large, private sector labs.

Testing Faces Lab Supply Shortages

Dwindling supplies include both chemical components and basic swabs needed to collect patient samples.

I Stock 1145760927

US Halts Inspections of Foreign Drug Plants

The agency announced it will postpone most foreign inspections scheduled through April, because of federal guidelines prohibiting travel.

In this Aug. 13, 2014 file photo, a therapist checks the ankle strap of an electrical shocking device on a student during an exercise program at the Judge Rotenberg Educational Center in Canton, Mass.

FDA Bans Shock Device

The ban follows years of pressure from disability rights groups and mental health experts who have called the treatment outdated, ineffective and unethical.

This Aug. 2, 2018, file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. Health officials reported the first U.S. drug shortage tied to the viral outbreak that is disrupting production in China, but they declined to identify the manufacturer or the product. The Food and Drug Administration said late Thursday, Feb. 27, 2020, that the drug's maker contacted health officials recently about the shortage, which it blamed on a manufacturing issue with the medicine's key ingredient.

Drug Shortage Tied to Outbreak

The drug's maker contacted officials about the shortage, which it blamed on a manufacturing issue with the medicine's key ingredient.

39 States Probe Juul's Marketing

'They’re in a world of hurt,” said James Tierney, a lecturer at Harvard Law School. “They can’t seriously litigate this.”

Moving company U-Haul has a new hiring policy and smokers need not apply. Starting this month the company will screen out people who use tobacco or nicotine when making new hires in certain U.S. states.

Company Anti-Tobacco Efforts Often Fail

Research shows little evidence that company wellness plans improve employee health or lower health care costs.